Takaya Mitsuyoshi

Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT.

J. Kanda, A. Yonezawa, A. Takaori-Kondo, 2020, Blood advances.

Comparison of reduced-intensity/toxicity conditioning regimens for umbilical cord blood transplantation for lymphoid malignancies

S. Fujiwara, K. Kawamura, J. Kanda, 2020, Bone Marrow Transplantation.

Impact of the combination of donor age and HLA disparity on the outcomes of unrelated bone marrow transplantation

K. Matsuo, S. Fujiwara, K. Kawamura, 2021, Bone Marrow Transplantation.

Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma

J. Kanda, S. Adachi, M. Nagao, 2022, Blood advances.

Real-World Outcomes of Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation in Japan: Retrospective Analysis of Transplant Registry Unified Management Program Registry: GVHD outcomes after allo-HSCT.

T. Ichinohe, Y. Atsuta, K. Matsuoka, 2024, Transplantation and cellular therapy.